Thursday, December 15, 2016

BRIEF-Cerenis receives FDA IND approval to begin studies with CER-209 in NAFLD and NASH

* Announced on Thursday that received FDA IND approval to begin studies with CER-209 in

NAFLD and NASH

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)